The State of Dentist-Led Facial Aesthetics in the UK 2026

This report examines the structure, scale and direction of dentist-led facial aesthetics in the United Kingdom, drawing on ClinicSpark's directory of 290 clinics across 82 cities and 51 counties, cross-referenced with the General Dental Council (GDC) register, the Care Quality Commission (CQC) register and Save Face's approved provider list. It covers the six months immediately following the CQC's October 2025 scope expansion, a period widely regarded as the most consequential in the history of UK non-surgical aesthetics regulation.

1. Executive summary

The UK non-surgical aesthetics market has, for more than a decade, operated in the space between unregulated beauty services and fully regulated medicine. Between October 2025 and April 2026, that space narrowed significantly. The Care Quality Commission's (CQC) expansion of its registration scope to cover injectable cosmetic procedures in England, combined with longstanding prescribing rules for Prescription-Only Medicines (POMs), has reshaped the market in favour of clinically qualified, regulated providers. Dentists, as General Dental Council (GDC)-registered healthcare professionals with prescribing authority and clinical premises already subject to infection-control standards, occupy a uniquely well-positioned segment of this new landscape.

ClinicSpark has tracked 290 UK dental practices that publicly advertise facial aesthetics services as of April 2026. The directory spans 82 cities and 51 counties, includes clinics from all four UK nations, and captures approximately 55,239 aggregated Google reviews with a mean rating of 4.80 out of 5.0. This report synthesises that directory data with publicly available regulator data and third-party market research to produce the most comprehensive public snapshot of the dentist-led facial aesthetics segment produced to date.

Headline findings

• Geographic concentration is extreme. London alone accounts for 21.7% of all listed clinics (63 of 290), with Greater London as a region representing 26.2% (76 of 290). The next nine cities combined account for a further 23.1%.
• England is overrepresented relative to population. 86.6% of dentist-led aesthetic clinics in the ClinicSpark directory are based in England, compared to 84.0% of the UK population. Scotland (8.3%), Wales (2.8%) and Northern Ireland (2.4%) are proportionally underrepresented.
• CQC registration is not universal but is now the majority. 144 of 290 tracked clinics (49.7%) appear on the CQC register as of April 2026. When the sample is restricted to English clinics offering injectables, the share rises to approximately 57%.
• Save Face accreditation remains niche. Only 15 of 290 listed clinics (5.2%) are currently Save Face-accredited, reflecting the voluntary nature of the accreditation and the cost of annual re-audit.
• Three core treatments dominate. Botulinum toxin treatments (administered under POM prescription), dermal fillers and lip augmentation account for the primary treatment menu of 64%+ of listed clinics. Emerging categories such as polynucleotides, RF microneedling and skin boosters remain small but are growing fastest in search volume.
• London commands a persistent price premium. Industry-reported pricing from comparable directories and clinic websites indicates London pricing is 20-30% above the national median across all major treatment categories, a gap that has widened slightly since 2024 as CQC compliance costs have compounded with London property overheads.

2. Market size and growth

The UK non-surgical aesthetics market

The UK non-surgical aesthetic treatments market — which includes botulinum toxin injections, dermal fillers, skin boosters, chemical peels, microneedling, laser treatments and related services — has grown from an estimated £2.75bn in 2019 to approximately £3.6bn by the end of 2024, according to market research aggregated by the British Beauty Council and third-party analysts. Industry estimates project continued compound growth of 7–9% per annum through 2028, although the 2025–2026 CQC regulatory transition has introduced unusual short-term uncertainty at the lower-priced, non-medic end of the market.

Injectable treatments — predominantly botulinum toxin (a Prescription-Only Medicine, or POM, under the Human Medicines Regulations 2012) and hyaluronic acid dermal fillers (currently regulated as medical devices rather than medicines) — are the largest single category, accounting for a majority share of non-surgical aesthetic spend in the UK.

The dentist-led share

Precise, directly reported market share figures for dentist-led provision are not currently published by any UK trade body. Estimates must therefore be constructed from regulator registers, directory data and primary research. The GDC register as of early 2026 lists more than 43,000 dentists eligible to practise in the UK; industry surveys conducted by dental trade publications over the past three years consistently place the proportion of dentists actively offering facial aesthetics at between 18% and 28%, with concentration heaviest among principals of private practices and associate dentists in urban areas.

Applying a conservative mid-point of that range to the registered population produces an estimate in the region of 8,500–12,000 GDC-registered dentists who offer some form of facial aesthetic service to patients, though many offer only a narrow menu (most commonly anti-wrinkle injections and lip augmentation).

ClinicSpark's directory of 290 clinics represents only those clinics that meet the directory's inclusion criteria: a UK-based dental practice with a publicly advertised facial aesthetics service offering, a verifiable web presence and a Google Business Profile. The directory therefore represents a conservative, clinic-level view of the segment rather than a practitioner-level view.

Drivers of growth

Three structural drivers underpin the continued expansion of dentist-led aesthetics in the UK:

1. CQC regulation. The October 2025 scope expansion means English clinics providing injectable cosmetic procedures must now register with the CQC. For dental practices, many of which are already CQC-registered for dental services, adding a cosmetic procedures regulated activity is a comparatively small marginal compliance step. For beauty salons and home-based operators with no prior healthcare registration, it is a substantially higher barrier.
2. Patient trust shift. Post-pandemic, patients report (per surveys run by Save Face, BACD and third-party market researchers) a stronger preference for treatment in a clinical environment and by a regulated healthcare professional. Dental surgeries — already understood by patients as clinical spaces — are natural beneficiaries of this shift.
3. Prescribing authority clarity. Dentists, as independent prescribers within their clinical competence, are lawfully able to prescribe botulinum toxin for cosmetic indications where clinically appropriate, subject to GDC scope-of-practice rules. This removes a structural dependency on remote prescribing services that has attracted regulatory attention in the non-medic segment.

3. Geographic distribution

Top UK cities by dentist-led aesthetic clinic count

London dominates the directory in absolute terms, containing more than three times as many listed clinics as the next largest city. This concentration tracks broader patterns in UK private healthcare, but the specific skew is even more pronounced in dentist-led aesthetics because of the confluence of high private-pay patient density, established cosmetic dentistry practices adding aesthetic services, and proximity to the specialist training and product supply ecosystem in central London.

Nation-level breakdown

The directory's nation-level distribution reflects the combined effects of population density, private dentistry market depth and the current regulatory landscape. CQC registration applies only to providers in England; Scotland regulates independent healthcare through Healthcare Improvement Scotland (HIS), Wales through Healthcare Inspectorate Wales (HIW), and Northern Ireland through the Regulation and Quality Improvement Authority (RQIA). Each of these four frameworks treats cosmetic injectables slightly differently, and the divergence has widened rather than narrowed in recent years.

County-level concentration

At county level the concentration pattern is even starker. The top five counties — Greater London, West Midlands, Kent, Tyne and Wear, and Glasgow — together account for 49.7% of all tracked dentist-led aesthetic clinics. The long tail is substantial: 31 counties in the directory have three or fewer listed clinics, reflecting the persistence of significant rural and semi-rural gaps in provision.

Urban versus market-town patterns

The directory reveals a distinct urban-versus-market-town pattern that is not visible in national aggregate figures alone. Prosperous market towns — notably Cheltenham, Harrogate, Royal Tunbridge Wells, Guildford, Chichester, Bath, York and Stratford-upon-Avon — appear consistently in the directory despite modest populations. In each of these towns, the listed clinics are predominantly long-established private dental practices that have added aesthetic services to an existing patient base rather than aesthetic-first businesses. This pattern contrasts with London and the larger regional cities, where a greater proportion of listed clinics were founded or rebranded specifically around aesthetics.

The implication is that market-town dentist-led aesthetics tends to rely on a consent model built on existing dental patient relationships, while urban provision depends more heavily on digital marketing, Google Business optimisation and referral networks from other cosmetic providers.

Regional price differentials

Pricing data cross-referenced from clinic websites and comparable aggregator data shows a persistent London premium across all major treatment categories. Median pricing for a single-area anti-wrinkle treatment (1 area) in London sits approximately 20–30% above the comparable median for the rest of England, with the gap widest in Central London (W1, WC1, SW1 postcodes) where some clinics report starting prices 40–60% above the national median. Scotland and Wales generally sit below the UK-wide median, while the South East outside London typically sits at or slightly above national median.

These differentials have widened modestly since early 2024, consistent with three forces: rising London commercial property costs, the incremental compliance cost of CQC registration (discussed in Section 5), and the concentration of the most highly credentialled aesthetic trainers and mentors in the capital, which supports a training-led pricing tier at the top end of the market.

4. Treatment trends

The dominant treatment menu

Across the 290 clinics in the ClinicSpark directory, three core injectable treatments define the bulk of the dentist-led menu:

Note: Botulinum toxin (including the brands Botox, Azzalure, Bocouture, Alluzience and Nuceiva) is a Prescription-Only Medicine under the Human Medicines Regulations 2012. It must be prescribed by a registered prescriber (doctor, dentist, pharmacist independent prescriber or nurse independent prescriber) following a face-to-face assessment of the specific patient for whom the prescription is being written. ClinicSpark treats all references to anti-wrinkle injections, Botox and similar branded products as POM throughout this report.

Emerging treatments

Beyond the core three, several treatment categories are growing rapidly in both search interest and clinic adoption, albeit from a small base. The most notable are:

• Polynucleotides. Originally introduced to the UK market in 2022–2023, polynucleotide treatments have grown substantially in consumer awareness through 2025 and into 2026. Search volume for "polynucleotides" and related queries in the UK grew an estimated 180% year-on-year to March 2026 per commonly cited keyword research tools.
• RF microneedling. Radiofrequency microneedling has moved out of the dermatology clinic and into a growing number of dental and medical aesthetic practices. Equipment cost remains a significant barrier (£25,000–£70,000 for a mid-range device), which concentrates adoption at the higher-priced and more established end of the market.
• Skin boosters. Hyaluronic acid-based injectable skin boosters (including Profhilo, Sunekos, Jalupro and Seventy Hyal) have become a standard upsell from lip and dermal filler consultations. They are classified as medical devices and, under the October 2025 CQC scope change, now fall within regulated activity in England.
• Tear trough treatment. Under-eye hyaluronic acid treatment has moved from a niche advanced technique to a mainstream offering, although complication risk (including vascular occlusion and Tyndall effect) means responsible providers now publish clearer consent and eligibility materials than in the 2020–2023 period.

Treatments in relative decline

A small number of treatment categories are becoming less visible on dentist-led aesthetic menus, either because they have become clinically outmoded, because of regulatory pressure, or because they have migrated toward more specialised providers. These include:

• Permanent (non-resorbable) fillers — long discouraged by UK professional bodies and, post-October 2025, strongly disfavoured under CQC expectations.
• Unbranded or parallel-import toxin products — use of non-UK licensed botulinum toxin products has narrowed sharply since the MHRA's communications over 2023–2025 concerning supply-chain authenticity.
• Dissolvable "lunchtime" lip flips without documented consultation — not a regulated category per se, but the ASA and CAP Code changes around "quick fix" claims have reduced the commercial viability of the lowest-priced, lowest-consultation treatment offers.

5. Regulatory landscape

The October 2025 CQC scope change

On 1 October 2025, the Care Quality Commission's scope of regulated activity expanded to cover a defined set of injectable cosmetic procedures in England. In practical terms, any provider in England offering specified injectable cosmetic procedures — predominantly botulinum toxin and dermal filler treatments — is expected to register with the CQC and to meet the CQC's fundamental standards, including those covering person-centred care, safeguarding, premises and equipment, and good governance.

The policy rationale, as set out by the Department of Health and Social Care in the consultation documents that preceded the scope change, was the long-standing mismatch between the clinical risk profile of injectable procedures and the regulatory treatment of the providers who administer them. Injectable cosmetic procedures carry established risks of vascular occlusion, infection, anaphylaxis and nerve injury — yet, prior to October 2025, these procedures could be performed in England by an entirely unregulated operator in an entirely unregulated premises, provided only that a prescriber somewhere in the supply chain had signed a prescription.

The scope change does not, by itself, restrict who can perform these procedures. A beauty therapist with no healthcare registration could still, in principle, register a cosmetic procedures business with the CQC, provided that business met the CQC's fundamental standards. In practice, however, the standards require a nominated individual, a registered manager, documented governance, infection-control procedures, consent procedures, and a safe environment, in addition to published safeguarding and complaint processes. For a typical beauty salon or home-based non-medic operator, the compliance burden is substantial. For a dental practice already registered with the CQC for dental services, adding a cosmetic procedures regulated activity is a much smaller marginal step.

GDC prescribing authority

The General Dental Council confirmed in guidance published during 2024 and reiterated in 2025 that dentists working within their scope of practice may prescribe Prescription-Only Medicines, including botulinum toxin, for cosmetic indications where clinically appropriate. Dentists are reminded that facial aesthetic treatments should be undertaken only after appropriate training, that they must maintain indemnity cover for those services, and that they remain subject to the GDC's Standards for the Dental Team and the Scope of Practice document throughout.

The clarity of prescribing authority is a meaningful structural advantage for the dentist-led segment. Unlike non-medic injectors, who depend on a separate prescribing relationship (typically with a doctor or nurse prescriber), dentists can assess, consent, prescribe and administer the treatment within a single clinical encounter — provided the prescribing dentist is the one performing the assessment.

ASA and CAP Code enforcement

The Advertising Standards Authority (ASA), supported by the Committee of Advertising Practice (CAP), has stepped up enforcement around advertising for cosmetic interventions. CAP's rules prohibit the promotion of Prescription-Only Medicines to the general public, mean that botulinum toxin and branded products such as Botox, Azzalure, Bocouture and Alluzience cannot be advertised by name or image to consumers. The ASA has published multiple enforcement rulings during 2024 and 2025 against clinics, social media influencers and platform-hosted accounts that breached these rules.

For clinics, this means that advertising claims around "Botox", before-and-after imagery featuring POM treatments, influencer promotion and time-limited discounts have all been specific enforcement targets. Compliant clinics now routinely refer to "anti-wrinkle injections" in consumer-facing materials, avoid brand names in advertising, and restrict POM-specific information to individual clinical consultations.

The regulatory gap for non-medic providers

Taking CQC, GDC, ASA/CAP and MHRA rules together, a coherent regulatory perimeter now exists around injectable cosmetic procedures in England. Dentist-led clinics sit comfortably inside that perimeter because they are already subject to healthcare regulation at both the premises level (via CQC) and the practitioner level (via GDC). Beauty-salon and home-based non-medic providers, by contrast, typically sit outside at least one of those layers. The 2025–2026 regulatory transition has, for the first time, given UK patients a set of checks they can run — CQC register, GDC register, Save Face register, MHRA yellow card history — that produces an objective answer about the regulatory status of their provider.

6. Trust and accreditation

CQC registration

In the ClinicSpark directory, 144 of 290 clinics (49.7%) are confirmed as appearing on the CQC register as of April 2026. When restricted to English clinics only (n=251), the share rises to approximately 57%. The gap between the directory share and 100% reflects a combination of three factors: clinics outside England that are regulated by HIS/HIW/RQIA rather than CQC; clinics in England whose CQC registration applications were filed but not yet approved as of the April 2026 cut-off; and a smaller residual group that have not yet completed registration and whose continued operation in England after the scope-change grace period is expected to come under active CQC review during 2026.

Save Face accreditation

Save Face — an industry accreditation scheme approved by the Professional Standards Authority — remains the most recognised voluntary accreditation in UK non-surgical aesthetics. In the ClinicSpark directory, 15 of 290 clinics (5.2%) are currently Save Face-accredited. The share is modest, but the scheme has grown steadily year on year; Save Face's own published register lists consistent annual growth in approved practitioner numbers from 2019 through 2025.

The gap between CQC registration and Save Face accreditation reflects the fundamentally different nature of the two: CQC registration is (in England) a legal requirement for premises delivering regulated activity, while Save Face accreditation is a voluntary, audited, annually renewed scheme focused on individual practitioners and specific clinics. Patients looking for an additional layer of assurance beyond CQC registration consistently identify Save Face as the first place they check.

BACD and BCAM

The British Academy of Cosmetic Dentistry (BACD) and the British College of Aesthetic Medicine (BCAM) are professional membership bodies, not accreditation schemes. BACD membership is relevant because many dentists active in facial aesthetics began with cosmetic dentistry and retain BACD membership; BCAM, while medically-led, has a small but meaningful dentist membership. Neither body appears in the ClinicSpark directory as a widely flagged trust badge — fewer than 1% of listings currently display either membership — but both are relevant to journalists and policymakers seeking to understand the professional development infrastructure that sits behind the clinical workforce.

What patients actually check

ClinicSpark's enquiry pattern data, combined with public search data, indicates that patients check — in approximate order of frequency:

1. Google reviews and star rating — by a wide margin the most checked signal.
2. Practitioner name and professional register entry (GDC, GMC, NMC).
3. CQC registration status (now rising sharply since October 2025).
4. Save Face accreditation (where patients have encountered the Save Face brand in media coverage).
5. Before-and-after imagery (notwithstanding the ASA/CAP restrictions on POM imagery, patients continue to seek compliant non-POM imagery).
6. Clinic website clinical detail — published consultation process, published complication policy, published pricing.

7. Price analysis 2026

Methodology note on pricing

The ClinicSpark directory does not aggregate advertised prices from individual clinic websites as a source of quoted figures for this report. Advertising of Prescription-Only Medicines to the public — including price-led promotion of "Botox" — is restricted under CAP Code rules, and ClinicSpark deliberately avoids republishing such material. The pricing figures set out in this section are drawn instead from published industry surveys, the Save Face consumer guidance, third-party aggregators that publish anonymised median pricing data, and editorially estimated typical ranges based on the sector. Ranges are stated, not single-point "average" figures, and they are explicitly not an offer or a recommendation.

Regional price variance

Three broad patterns are consistent across multiple UK pricing datasets:

1. Central London commands a 20–30% premium over the national median in the core injectable categories, with a further premium at the elite end (W1 / SW1 / SW3 / NW8 postcodes).
2. Scotland and Wales sit slightly below the national median in most categories, with Edinburgh and Cardiff exceptions that track national urban pricing.
3. Prosperous market towns in the South East (Tunbridge Wells, Guildford, Chichester, Winchester) price close to outer London, driven by private-pay patient density.

Cost drivers

Three structural factors are pushing clinic pricing modestly upward in 2026 relative to 2024:

• Training and ongoing CPD. Advanced aesthetic training in the UK now typically costs £4,000–£15,000 per practitioner for the foundational pathway, with ongoing CPD and mentorship commitments of several thousand pounds annually at the premium end.
• Indemnity cover. Medical indemnity insurance premiums for dental practitioners adding facial aesthetics to their scope have risen materially over the 2023–2026 window, reflecting claims experience across the sector rather than dentist-specific claim frequency.
• CQC compliance. The incremental cost of CQC registration — application fees, policy development, registered manager role, ongoing inspection readiness — adds modestly but persistently to the cost base of compliant clinics. This is a clear fixed-cost hurdle that disproportionately falls on small providers.

8. Patient behaviour

Search behaviour

UK search volume trends over the past 12 months confirm a clear, sustained rise in patient preference for qualified, regulated providers. Queries containing "dentist" as a provider modifier — for example, "lip fillers dentist near me" and "botox dentist [city]" — have grown materially year on year across popular keyword research tools. The growth is strongest in London, Greater Manchester, Birmingham and the south-coast English towns, where search volume for dentist-qualified providers now routinely exceeds queries that do not specify provider type.

Queries such as "CQC registered aesthetic clinic", "Save Face dentist" and "is my aesthetic clinic regulated" have also grown substantially since October 2025. This is a direct, measurable patient response to the CQC scope change and to the increased media coverage of regulatory enforcement actions.

Consultation-first versus treatment-first preference

Historically, a substantial share of UK non-surgical aesthetic bookings were made directly for treatment, with consultation combined with treatment on the same visit. Since 2023, and more sharply since the CQC scope change, the share of patients booking a consultation-only first visit has risen noticeably. This shift maps to both regulatory expectations (the CQC's consent and cooling-off expectations) and to patient preference for a more considered pathway, particularly among first-time patients.

For dentist-led clinics, the consultation-first pattern is structurally easier to deliver than it is for high-volume non-medic operators, because a dental practice is already configured around chair-time appointments with patient-specific planning.

Demographics

Industry demographic surveys — including those published by Save Face and by independent aesthetic trade research — consistently show the UK non-surgical aesthetics patient base is:

• Approximately 85–90% female in aggregate, with the male share highest in anti-wrinkle treatments and in 18–34 age bands for jawline/chin filler.
• Modally 30–49 by age, with growing cohorts at 25–29 (preventative anti-wrinkle and lip augmentation) and 55+ (skin boosters, polynucleotides, bio-remodellers).
• Strongly concentrated in the upper half of the UK household income distribution, with meaningful regional variation.

Dentist-led clinics typically report a patient demographic slightly older and more evenly gender-distributed than the aesthetics-only national average, reflecting the age and gender profile of established dental patient bases from which aesthetic services are cross-sold.

9. What this means for the industry

Consolidation opportunities

The combination of CQC registration costs, rising indemnity premiums and ongoing training investment creates a meaningful fixed-cost floor for compliant operators. Below a certain volume of weekly treatments, an independent aesthetic clinic struggles to absorb those fixed costs profitably. The predictable consequence — already visible in press reports and trade coverage — is consolidation: larger dentist-led groups are adding aesthetic services to existing multi-site dental chains, and specialist aesthetic chains are adding dental practitioners to their clinical teams. The directory as it stood in April 2026 is best understood as a snapshot mid-way through that process.

Compliance as differentiator

For a large share of patients, CQC registration has moved from being a largely invisible background fact to an actively marketed differentiator. Clinics that display their CQC registration prominently — and that publish their most recent CQC inspection outcomes — are rewarded with materially higher click-through and enquiry rates in directory data. Save Face accreditation, while still a minority signal in the directory as a whole, is an increasingly powerful trust multiplier when combined with CQC registration and GDC practitioner verification.

The regulatory fence closes

Three years ago the UK non-surgical aesthetics market could reasonably be described as a loosely regulated cottage industry with a small well-regulated core. The evidence gathered for this report suggests that, by the end of 2026, that description will no longer be accurate. The CQC scope change, ASA/CAP enforcement, MHRA supply-chain communications, GDC scope-of-practice clarity and the steady growth of Save Face have together produced an identifiable regulatory perimeter inside which regulated healthcare professionals — dentists prominent among them — operate, and outside which a residual non-medic market will continue to exist but under meaningfully increasing regulatory pressure.

For patients, the clearest practical takeaway is that the checks they can now run — CQC, GDC, Save Face, Google Business Profile reviews and directly visible consultation practice — are more substantive, and more enforceable, than at any previous point in the sector's history.

10. Methodology

Data sources

• ClinicSpark directory data (n=290 dentist-led clinics as at April 2026). Inclusion criteria: UK-based dental practice; publicly advertised facial aesthetics service; verifiable web presence; Google Business Profile. Cities and counties are normalised to Office for National Statistics (ONS) geography.
• General Dental Council (GDC) register. Cross-referenced at practitioner level where practitioner names are publicly disclosed by the clinic.
• Care Quality Commission (CQC) register. Cross-referenced at provider/location level for all English clinics.
• Save Face register. Cross-referenced at practitioner and clinic level.
• Google Business Profile data. Star rating and aggregate review count captured via published Google Business listings. Individual review content is not analysed or reproduced.
• Public market research. Industry size estimates referenced in Section 2 draw on published British Beauty Council research, consistently cited figures from the Save Face annual industry snapshot, and published reports from third-party market research organisations.

Time period

Directory cut-off: 9 April 2026. CQC and GDC register checks: ongoing, most recent cycle completed 3–9 April 2026. Save Face register check: 9 April 2026. Report published 10 April 2026; last reviewed 15 April 2026.

Limitations

This report is subject to several structural limitations that readers should bear in mind when citing figures.

• Directory coverage is not a census. ClinicSpark's directory represents dentist-led facial aesthetic providers that meet the inclusion criteria above; it does not purport to list every GDC-registered dentist in the UK who has ever administered an aesthetic treatment. Smaller single-practitioner operators without a distinct clinic web presence are systematically underrepresented.
• Self-reported treatment menus. Treatment categories are captured from each clinic's publicly stated treatment menu. Compliance with CAP Code restrictions on POM advertising means that some clinics deliberately do not publish a Botox/anti-wrinkle heading; those clinics may still lawfully offer the treatment in-clinic.
• Market share estimates are indicative. The dentist-led share of the overall UK non-surgical aesthetics market is not directly reported by any UK trade body. The figures presented in Section 2 are constructed from regulator data and industry surveys, and are stated as ranges rather than as point estimates.
• Pricing figures are ranges, not averages. Pricing is subject to CAP Code restrictions and is reported only as indicative ranges drawn from multiple industry sources. No individual clinic's advertised pricing is republished in this report.
• Regulatory positions evolve. CQC, GDC, ASA/CAP and MHRA positions are subject to change. Readers should check the relevant regulator's own published material for the most current position on any specific point.

11. How to cite this report

Journalists, trade press, academic researchers and industry analysts are welcome to quote and cite this report. A short (fewer than 15-word) quotation in context does not require prior permission. For any longer quotation, data reuse or reproduction of tables, please contact the Editorial Team in advance at press@clinicspark.co.uk.

Suggested citation formats

Short form (in-text):
ClinicSpark, "The State of Dentist-Led Facial Aesthetics in the UK 2026," April 2026.

Long form (bibliography / reference list):
ClinicSpark Editorial Team (2026). The State of Dentist-Led Facial Aesthetics in the UK 2026: market size, geographic distribution, regulatory landscape, pricing and patient behaviour. ClinicSpark, 10 April 2026. Available at: https://clinicspark.co.uk/state-of-uk-aesthetics-2026/

When citing specific figures: please include the figure, the table or section reference, and the report title and publication date, for example:
"Forty-nine point seven per cent of tracked dentist-led clinics were confirmed CQC-registered as of April 2026 (ClinicSpark, State of Dentist-Led Facial Aesthetics in the UK 2026, Table 6.1)."

Published 10 April 2026 · Last reviewed 15 April 2026 · ClinicSpark Editorial Team · About ClinicSpark · Verification methodology